Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(100.0%)
3Total
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02237781Phase 2Unknown

Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins

Role: collaborator

NCT02237755Phase 2Unknown

Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.

Role: collaborator

NCT02099916Phase 2Unknown

Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF

Role: collaborator

All 3 trials loaded